Meet And Network With The Key Influencers Shaping The Law, Policy And Proceedings of Paragraph IV Litigation

Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation.

As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.

The 2020 Agenda Features Exclusive Keynotes, In-depth Focus Sessions, and Extended Networking Opportunities

FIRESIDE CHAT WITH THE FEDERAL CIRCUIT

Exclusive interview with the Hon. Kathleen M. O’Malley,
United States Circuit Judge

FTC KEYNOTE ADDRESS

Insights on antitrust developments impacting brands and generics

DISTRICT COURT INSIGHTS

Interactive discussions with District Court Judges and Magistrate Judges from D.N.J.; D. Del.; E.D. Pa.; E.D. Tex.

FDA THINK TANK

Initiatives impacting drug access and litigation

SPECIAL FOCUS SESSIONS ON THE PTAB

APJs Roundtable and advanced discussions on policy, practice, procedure, and the Appointments Clause

FOUR NEW BREAKOUT TRACKS

Featuring an In-House Solutions Studio and Litigators War Room

EXTENDED NETWORKING BREAKS

Connect and reconnect with industry colleagues and establish new relationships

Icon

300+

Attendees

Icon

15+

Esteemed Judges & Government Enforcers

Icon

100+

Companies on the Faculty & Advisory Board

Icon

3

Days of Networking

MEET THE 2020 C0-CHAIRS
Brian Anderson

Brian Anderson

Vice President & Assistant General Counsel IP Litigation
Allergan

Pearl Slew

Pearl Slew

Senior Vice President and Head Intellectual Property
Eagle Pharmaceuticals, Inc (Woodcliff Lake, NJ)

2020 KEY FEATURES

Day 1
April 27

TWO NEW BREAKOUT TRACKS
In-depth coverage on the solution and practice of Paragraph IV litigation and settlement

FIRESIDE CHAT WITH THE FEDERAL CIRCUIT
Exclusive interview with Hon. Kathleen M. O’Malley

SPECIAL PTAB FOCUS SESSIONS
APJs Roundtable and advanced discussions on policy, practice, procedure, and the Appointments Clause

Day 2
April 28

FTC KEYNOTE ADDRESS
Insight on antitrust developments impacting brands and generics

FDA THINK TANKS
Initiatives impacting drug access and litigation

DISTRICT COURT INSIGHTS
Interactive discussions with District Court Judges and Magistrate Judges from D.N.J.; D. Del.; E.D. Pa.; E.D. Tex.

Post-Conference Workshops
April 29

TARGETED THINK TANKS
Enhanced learning opportunities for seasoned practitioners and the next generation

  • State and Federal Pharmaceutical IP Antitrust Initiatives
  • Winning Strategies at the District Court and IPR Parallel Proceedings
WHO YOU WILL MEET

Patent attorneys and litigators (in-house & law firms) who represent:

  • Brand name pharmaceutical companies
  • Generic pharmaceutical companies
  • Biopharmaceutical companies
TESTIMONIALS
Quote Icon

This is the best high-level conference on Paragraph IV disputes…

Senior VP, Intellectual Property
Endo Pharmaceuticals
Quote Icon

…the smaller breakout sessions allow participants to tailor their conference experience to meet their specific needs, and exchange ideas in an intimate and dynamic environment

Senior VP and Head, Intellectual Property
Eagle Pharmaceuticals

Attend the conference that the “Who’s Who” of Hatch-Waxman litigators have designated as the forum which sets the standards for Paragraph IV practice. Register now and be part of the prestigious meeting of the minds.

Register Now and Enjoy Early Bird Savings!


Hotel

Conrad Hotel

102 North End Avenue, New York, NY 10282

Book Now